MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 592465 | Name: Albendazole oxide
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Albendazole oxide is a Antiparasitic Agent.

Chemical Structure

Albendazole oxide
Albendazole oxide
CAS#54029-12-8 (sulfoxide)

Theoretical Analysis

MedKoo Cat#: 592465

Name: Albendazole oxide

CAS#: 54029-12-8 (sulfoxide)

Chemical Formula: C12H15N3O3S

Exact Mass: 281.0834

Molecular Weight: 281.33

Elemental Analysis: C, 51.23; H, 5.37; N, 14.94; O, 17.06; S, 11.40

Price and Availability

Size Price Availability Quantity
5g USD 250.00 2 Weeks
10g USD 400.00 2 Weeks
25g USD 650.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
1287076-43-0 (deuterated_d7) 54965-21-8 75184-71-3 (sulfone) 54029-12-8 (sulfoxide)
Synonym
Albendazole oxide; RS 8852; RS-8852; RS8852, Albendazole sulfoxide; Ricobendazole
IUPAC/Chemical Name
Carbamic acid, (5-propylsulfinyl)-1H-benzimidazol-2-yl)-, methyl ester
InChi Key
VXTGHWHFYNYFFV-UHFFFAOYSA-N
InChi Code
InChI=1S/C12H15N3O3S/c1-3-6-19(17)8-4-5-9-10(7-8)14-11(13-9)15-12(16)18-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
SMILES Code
O=C(OC)NC1=NC2=CC(S(CCC)=O)=CC=C2N1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 281.33 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Zhu L, Kuang X, Zhang G, Liang L, Liu D, Hu B, Xie Z, Li H, Liu H, Ye M, Chen X, Liu J. Albendazole induces immunotherapy response by facilitating ubiquitin- mediated PD-L1 degradation. J Immunother Cancer. 2022 May;10(5):e003819. doi: 10.1136/jitc-2021-003819. PMID: 35577504; PMCID: PMC9115032. 2: Dharnidharka VR, Agrawal M, Dandge VP. Albendazole. Indian Pediatr. 1993 Sep;30(9):1115-8. PMID: 8125597. 3: Curtiss P, Cobos G, Sicco KL, Seminara N. Acute Alopecia Associated With Albendazole Toxicosis. Cutis. 2022 May;109(5):E43-E45. doi: 10.12788/cutis.0548. PMID: 35856765. 4: Garg D, Sharma S. Albendazole for Neurocysticercosis in Children: How Long is Long Enough? Indian Pediatr. 2022 Dec 15;59(12):909-910. PMID: 36511204. 5: Movahedi F, Li L, Gu W, Xu ZP. Nanoformulations of albendazole as effective anticancer and antiparasite agents. Nanomedicine (Lond). 2017 Oct;12(20):2555-2574. doi: 10.2217/nnm-2017-0102. Epub 2017 Sep 28. PMID: 28954575. 6: Albanese G, Venturi C. Albendazole: a new drug for human parasitoses. Dermatol Clin. 2003 Apr;21(2):283-90. doi: 10.1016/s0733-8635(02)00085-2. PMID: 12757251. 7: Koca T, Akcam M. Albendazole-induced autoimmune hepatitis. Indian Pediatr. 2015 Jan;52(1):78-9. PMID: 25638200. 8: Smith AL, Rego LP, Williams R. Albendazole monitoring. Am J Health Syst Pharm. 1997 Feb 1;54(3):319-20. doi: 10.1093/ajhp/54.3.319. PMID: 9028426. 9: Dayan AD. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop. 2003 May;86(2-3):141-59. doi: 10.1016/s0001-706x(03)00031-7. PMID: 12745134. 10: Oxberry ME, Reynoldson JA, Thompson RC. The binding and distribution of albendazole and its principal metabolites in Giardia duodenalis. J Vet Pharmacol Ther. 2000 Jun;23(3):113-20. doi: 10.1046/j.1365-2885.2000.00254.x. Erratum in: J Vet Pharmacol Ther 2001 Apr;24(2):158-60. PMID: 11110097. 11: Verdugo Thomas F, Tapia Mingo A, Ramírez Montes D, Oporto Uribe S. Hepatitis tóxica por albendazol [Albendazole-induced toxic hepatitis]. Gastroenterol Hepatol. 2015 Aug-Sep;38(7):436-8. Spanish. doi: 10.1016/j.gastrohep.2014.08.001. Epub 2014 Aug 30. PMID: 25179365. 12: Gross U. Treatment of microsporidiosis including albendazole. Parasitol Res. 2003 Jun;90 Supp 1:S14-8. doi: 10.1007/s00436-002-0753-x. Epub 2002 Dec 10. PMID: 12811545. 13: Horton J. Echinococcosis and Albendazole: A Case for Suitable Treatment. Am J Trop Med Hyg. 2018 Oct;99(4):811-812. doi: 10.4269/ajtmh.18-0609. PMID: 30141399; PMCID: PMC6159601. 14: Capece BP, Virkel GL, Lanusse CE. Enantiomeric behaviour of albendazole and fenbendazole sulfoxides in domestic animals: pharmacological implications. Vet J. 2009 Sep;181(3):241-50. doi: 10.1016/j.tvjl.2008.11.010. Epub 2009 Jan 4. PMID: 19124257. 15: Auer H, Kollaritsch H, Jüptner J, Aspöck H. Albendazole and pregnancy. Appl Parasitol. 1994 Jun;35(2):146-7. PMID: 8087155. 16: Eriksen JB, Christensen SB, Bauer-Brandl A, Brandl M. Dissolution/Permeation of Albendazole in the Presence of Cyclodextrin and Bile Salts: A Mechanistic In Vitro Study into Factors Governing Oral Bioavailability. J Pharm Sci. 2022 Jun;111(6):1667-1673. doi: 10.1016/j.xphs.2021.11.010. Epub 2021 Nov 20. PMID: 34808218. 17: Paredes AJ, Bruni SS, Allemandi D, Lanusse C, Palma SD. Albendazole nanocrystals with improved pharmacokinetic performance in mice. Ther Deliv. 2018 Feb;9(2):89-97. doi: 10.4155/tde-2017-0090. PMID: 29325510. 18: Permana AD, Paredes AJ, Zanutto FV, Amir MN, Ismail I, Bahar MA, Sumarheni, Palma SD, Donnelly RF. Albendazole Nanocrystal-Based Dissolving Microneedles with Improved Pharmacokinetic Performance for Enhanced Treatment of Cystic Echinococcosis. ACS Appl Mater Interfaces. 2021 Aug 18;13(32):38745-38760. doi: 10.1021/acsami.1c11179. Epub 2021 Aug 5. PMID: 34353029. 19: Schulz JD, Neodo A, Coulibaly JT, Keiser J. Pharmacokinetics of Albendazole, Albendazole Sulfoxide, and Albendazole Sulfone Determined from Plasma, Blood, Dried-Blood Spots, and Mitra Samples of Hookworm-Infected Adolescents. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02489-18. doi: 10.1128/AAC.02489-18. PMID: 30745388; PMCID: PMC6437472. 20: Zhang QL, Lian DD, Zhu MJ, Li XM, Lee JK, Yoon TJ, Lee JH, Jiang RH, Kim CD. Antitumor Effect of Albendazole on Cutaneous Squamous Cell Carcinoma (SCC) Cells. Biomed Res Int. 2019 Jun 9;2019:3689517. doi: 10.1155/2019/3689517. PMID: 31281836; PMCID: PMC6590486.

View History

HUN86681

HUN86681